
==== Front
JACC Case Rep
JACC Case Rep
JACC Case Reports
2666-0849
Elsevier

S2666-0849(24)00252-3
10.1016/j.jaccas.2024.102459
102459
Valvular Heart Disease
Editorial Comment
Paroxysmal or “Eclipsed” Mitral Regurgitation
An Entity With Serious Consequences
Avierinos Jean-Francois MD Jean-francois.avierinos@ap-hm.fr
a∗
Walsh Mary Norine MD b
Enriquez-Sarano Maurice MD c
a Département de Cardiologie, Centre hospitalier universitaire Timone, Assistance Publique Hôpitaux de Marseille, Aix Marseille Université, Marseille, France
b Ascension St Vincent Heart Center, Indianapolis, Indiana, USA
c Minneapolis Heart Institute, Minneapolis, Minnesota, USA
∗ Address for correspondence: Dr Jean-Francois Avierinos, Département de Cardiologie, 10ème étage, Hôpital Timone adulte, 264 rue Saint Pierre, 13005 Marseille, France. Jean-francois.avierinos@ap-hm.fr
21 8 2024
21 8 2024
21 8 2024
29 16 102459© 2024 The Authors
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Corresponding Author

Key Words

acute heart failure
eclipsed
functional
mitral regurgitation
==== Body
pmcThe Deepening Conundrum of Functional Mitral Regurgitation

Functional (or secondary) mitral regurgitation (FMR) is the regurgitation occurring with structurally normal or near-normal mitral leaflets.1 FMR has long been considered exclusively associated with global/regional left ventricular (LV) systolic dysfunction or remodeling, of ischemic or nonischemic origin, of uncertain mechanism and of uncertain prognostic significance.2 With improved imaging, extensive cohorts, and clinical trials, understanding of mechanisms and outcome impact of FMR has been clarified. Mechanistically, although mitral annular flattening, dilation, and loss of contraction are all operative in generating FMR,3 alterations of subvalvular support with displacement of papillary muscles and valvular tenting are major determinants of FMR severity.4 FMR worsens the causal LV dysfunction outcome,5,6 which is considerably improved by transcatheter mitral valve repair.7 Thus, FMR is a crucial and treatable component of heart failure (HF) with reduced ejection fraction. However, the FMR conundrum has deepened further. Recently, identification of a new subtype of FMR different from the ventricular FMR and associated with predominant atrial remodeling while the left ventricle appears normal, has been emphasized,8 often in association with longstanding atrial fibrillation9 and/or LV diastolic dysfunction10; however, it remains a mystery in many aspects.11

A most striking conundrum of mitral regurgitation (MR) is related to its dynamic nature and to the possibility of paroxysmal variation of FMR severity. Dynamic changes of primary MR severity throughout systole in the setting of mitral valve prolapse are well known,12 as are changes of FMR related to fluctuations of loading conditions,13 HF medications,14,15 or resynchronization therapy.16 One special form of MR variation is the increase of effective regurgitant orifice of ventricular FMR reported during exercise, which indicates that the severity of the regurgitant lesion can acutely increase under certain circumstances, and can be associated with acute HF.17 However, the sudden appearance and disappearance of FMR has been rarely reported as “eclipsed mitral regurgitation,”18 a term intended to underscore the paroxysmal and complete nature of this appearance/disappearance. This type of MR is by nature functional because it is not just variable but is replaced by nearly complete restauration of leaflets’ coaptation between acute phases and without significant primary mitral valve anomaly.19 The demonstration of the existence of such paroxysmal, eclipsing FMR raises several important questions regarding its prevalence, mechanisms, and consequences.

Since its first mention,18 only a small series19 and few clinical cases20, 21, 22, 23, 24, 25 have been reported, suggesting either an extreme rarity of the condition or an underdiagnosis due to the paroxysmal nature of the leak and its prompt usual disappearance with acute HF treatment, and or changes in hemodynamics and loading conditions.18,22 Only cases in which immediate echocardiography was performed during the acute phase of HF were detected, and it is possible that many cases are missed due to the lack of prompt imaging and auscultation. The mechanism of paroxysmal FMR is an acute lack of coaptation between mitral leaflets leading to acute HF,18,19 but the reasons for such loss of coaptation remain uncertain. In the patients involved, the supposed final diagnosis of acute HF18,19 is frequently that of HF with preserved ejection fraction (HFpEF), an entity that remains poorly understood. Whether eclipsed MR is a more frequent component of HFpEF than generally thought remains to be investigated.

The Present Cases: Paroxysmal FMR With HFpEF

In this issue of JACC: Case Reports, 2 reports emphasize the importance of eclipsed FMR. Kitamura et al26 present the clinical case of a postmenopausal woman with past history and severe symptoms of recurrent episodes of acute pulmonary edema, which were ultimately attributed to paroxysmal acute massive restrictive FMR in the absence of preexisting significant mitral leak or LV systolic dysfunction remodeling, the so-called eclipsed MR. The acute FMR was reproduced by handgrip testing, and imaging showed that mechanistically the loss of mitral coaptation was related to systolic restriction of the mitral leaflets (type IIIb mechanism of Carpentier), with considerable separation of the tenting leaflets and FMR appearing massive in degree, providing an obvious explanation for the abrupt hemodynamic deterioration of the patient with pulmonary edema and hypotension. Prompt symptomatic recovery was associated with restoration of mitral coaptation. The authors concerned by the recurrent pulmonary edema under medical treatment decided to perform a transcatheter mitral edge-to-edge repair, with a result of no recurrence of paroxysmal FMR during a short follow-up. In the same issue, Knott et al27 present the case of an 83-year-old woman with paroxysmal HF who developed positional severe FMR with acute exacerbation of the FMR and HF, with marked exacerbation of mitral tenting demonstrated by 3-dimensional echo. Here again, the patient was treated by transcatheter mitral edge-to-edge repair, which prevented the positional recurrence of eclipsed FMR and paroxysmal HF.

The Kitamura et al26 case is not a case of isolated eclipsed MR due to the presence of known apical hypertrophic cardiomyopathy (HCM).26 Although MR in HCM is usually associated with systolic anterior motion of mitral leaflets, such is not the case with apical HCM.28 Whether paroxysmal FMR in this patient was related to LV diastolic dysfunction,10 and/or abnormal mitral position due to the HCM, is putative.29

Coronary angiogram, as in previous cases, was normal (ie, nonobstructive), but provocative maneuvers with coronary imaging were not performed. Imaging during development of the paroxysmal FMR showed some mechanistic information with acute left atrial and LV dilatation during the episodes. Was it the mechanistic cause or consequence? Although the occurrence of paroxysmal MR may cause atrial and ventricular dilatation, the sudden tenting of mitral leaflets suggests acute papillary muscle displacement as directly responsible for the paroxysmal FMR. However, the primary cause of these changes is not understood. Is it an acute atrial remodeling with acute annular deformation,20 secondary to sudden increase in preload,24 to an acute widening of the papillary muscles separation such as in acute myocardial infarction,22 or in Takatsubo-like ventricular alterations,23 due to coronary spasm as suggested by methylergonovine MR triggering,18 or due to an excess afterload-related LV dilation as hypothesized by the authors? Although the present cases cannot resolve these questions, the observation of paroxysmal tenting of mitral leaflet causing paroxysmal FMR is crucial.26 Other important information regard the severity of the HFpEF caused by the paroxysmal FMR, with recurrent pulmonary edemas, already reported30 but essential to underscore. This complication of paroxysmal FMR can indeed be life-threatening, requiring repeated admission in intensive care units, sometimes necessitating ventilatory support,19 and resulting in cardiogenic shock22 or cardiac arrest.19 The diagnosis of paroxysmal FMR as the source of these complications is difficult, with reported erroneous diagnosis of precapillary pulmonary hypertension before the eclipsed FMR diagnosis was uncovered.24 This profound diagnostic uncertainty prevents the investigation of the role of paroxysmal FMR in the advent of HFpEF and systematic prospective mechanistic and therapeutic evaluations.

Paroxysmal FMR and HF: Where Do We Go From Here?

Over the years, little progress has been made in the concepts regarding eclipsed MR due to the lack of acute imaging of patients presenting with HF. If, as we suspect, paroxysmal FMR plays an underestimated role in HFpEF, prompt imaging of patients presenting with suspected acute HF in the emergency department is key to revealing this potential role,17 and predefined Doppler echocardiographic protocols will be crucial in these emergency situations. Besides demonstration of acute FMR, secondary imaging protocols should also be devised. Although methylergonovine testing18 appears ineffective in most cases,19,21,23 preload or afterload stress testing may be considered by leg elevation,24 exercise,25 handgrip as in the present report, or possibly epinephrine infusion.23 Preadministration of nitrates may make these tests ineffective and should be avoided. Once identified, the treatment of paroxysmal FMR remains poorly defined and requires collaborative evaluation. Acutely, medical treatment, particularly nitrates,18 may have a spectacular effect, even in the most serious presentations.22 Counterintuitive beneficial effect of dobutamine and norepinephrine has been reported.25 Long-term treatment by calcium channel blockers appears transiently effective.18 Mitral valve replacement,19,21,23,24 or transcatheter mitral valve repair,25,29 has been used with good short-term outcomes, but uncertainty regarding long-term outcomes warrants well-designed multicenter trials. It is our plea that paroxysmal FMR be evaluated in collaborative multicenter series to elucidate the unresolved conundrum of eclipsed MR.

Funding Support and Author Disclosures

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
==== Refs
References

1 Enriquez-Sarano M. Akins C.W. Vahanian A. Mitral regurgitation. Long-term outcomes comparing minimally invasive mitral valve repair versus conventional mitral valve surgery Lancet 373 2009 1382 1394 19356795
2 Perloff J. Roberts W. The mitral apparatus. Functional anatomy of mitral regurgitation Circulation 46 2 1972 227 239 5046018
3 Topilsky Y. Vaturi O. Watanabe N. Real-time 3-dimensional dynamics of functional mitral regurgitation: a prospective quantitative and mechanistic study J Am Heart Assoc 2 3 2013 e000039
4 Yiu S.F. Enriquez-Sarano M. Tribouilloy C. Seward J.B. Tajik A.J. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study Circulation 102 2000 1400 1406 10993859
5 Grigioni F. Enriquez-Sarano M. Zehr K. Bailey K. Tajik A. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment Circulation 103 2001 1759 1764 11282907
6 Benfari G. Antoine C. Essayagh B. Functional mitral regurgitation outcome and grading in heart failure with reduced ejection fraction JACC Cardiovasc Imaging 14 12 2021 2303 2315 34274275
7 Stone G. Lindenfeld J. Abraham W. Transcatheter mitral-valve repair in patients with heart failure N Engl J Med 379 24 2018 2307 2318 30280640
8 Dziadzko V. Dziadzko M. Medina-Inojosa J. Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome Eur Heart J 40 27 2019 2194 2202 31121021
9 Gertz Z. Raina A. Saghy L. Evidence of atrial functional mitral regurgitation due to atrial fibrillation reversal with arrhythmia control J Am Coll Cardiol 58 2011 1474 1481 21939832
10 Tamargo M. Obokata M. Reddy Y. Functional mitral regurgitation and left atrial myopathy in heart failure with preserved ejection fraction Eur J Heart Fail 22 2020 489 498 31908127
11 Essayagh B. Enriquez Sarano M. Atrial functional mitral regurgitation: many questions few answers JACC Cardiovasc Imaging 15 11 2022 1852 1855 36357128
12 Enriquez-Sarano M. Sinak L. Tajik A. Bailey K. Seward J. Changes in effective regurgitant orifice throughout systole in patients with mitral valve prolapse. A clinical study using the proximal isovelocity surface area method Circulation 92 1995 2951 2958 7586265
13 Rosario L. Stevenson L. Solomon S. Lee R. Reimold S. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size J Am Coll Cardiol 32 1998 1819 1824 9857857
14 Seneviratne B. Moore G. West P. Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomized double blind trial Br Heart J 72 1994 63 68 8068472
15 Lowes B.D. Gill E.A. Abraham W.T. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure Am J Cardiol 83 1999 1201 1205 10215284
16 Breithardt O.A. Sinha A.M. Schwammenthal E. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure J Am Coll Cardiol 41 2003 765 770 12628720
17 Pierard L.A. Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema N Engl J Med 351 2004 1627 1634 15483281
18 Avierinos J. Thuny F. Tafanelli L. Eclipsed mitral regurgitation: a new form of functional mitral regurgitation for an unusual cause of heart failure with normal ejection fraction Cardiology 110 1 2008 29 34 17934266
19 Milleron O. Bouleti C. Mazouz S. Eclipsed mitral regurgitation: an unusual cause of acute heart failure Eur Heart J Cardiovasc Imaging 18 2017 1163 1169 27625364
20 Labbe V. Charlier P. Brocher E. Iung B. Vahanian A. Messika-Zeitoun D. Transient severe reversible functional mitral regurgitation: a three-dimensional transoesophageal perspective Eur J Echocardiogr 11 3 2010 E3
21 Messas N. Samet H. Brocchi J. Mitral valve surgery for transient severe mitral regurgitation: An alternative to medical treatment? Int J Cardiol 175 3 2014 e40 e42 24874900
22 Kimura M. Kohno T. Murata M. Oral nitrate administration ameliorates cardiogenic shock due to eclipsed mitral regurgitation Cardiology 134 3 2016 327 330 26981622
23 Ichikawa K. Watanabe A. Ito H. Eclipsed mitral regurgitation successfully treated with a combination of surgical and pharmacological therapies: a case report Eur Heart J Case Rep 3 2019 1 5
24 Jain C. Egbe A. Borlaug B. Every now and then I fall apart: total eclipse of the mitral valve Circ Heart Fail 13 10 2020 e007145
25 Umei T. Shiraishi Y. Tsuruta H. Transcatheter mitral valve repair effective and safe for refractory eclipsed mitral regurgitation-induced cardiogenic shock: a case report Circ Cardiovasc Imaging 14 7 2021 e012641
26 Kitamura S. Asami M. Tanaka J. Paroxysmal mitral regurgitation treated by edge-to-edge repair JACC Case Rep 29 2024 102473
27 Knott J. Luoma C. Pearce A. A novel presentation of eclipsed mitral regurgitation JACC Case Rep 29 2024 102460
28 Schwammenthal E. Nakatani S. He S. Mechanism of mitral regurgitation in hypertrophic cardiomyopathy: mismatch of posterior to anterior leaflet length and mobility Circulation 98 1998 856 865 9738640
29 Bourque C. Dijos M. Leroux L. Eclipsed functional mitral regurgitation destabilizing hypertrophic cardiomyopathy: an unusual case treated with MitraClip CJC Open 3 5 2020 680 683 34027373
30 Oyama S. Ohuchi S. Yamazaki Y. Kumagai K. Harima T. Mitral valve replacement for eclipsed mitral regurgitation with multiple episodes of acute exacerbation ad remission Kyobu Geka 76 11 2023 917 921 38056948
